Term ended Oct 26, 2026 · High confidence
20-year base term ended Oct 26, 2026
Held by Impact Biomedicines, Inc.
Filed Aug 24, 2010 as application 12/862,517 · Granted Dec 10, 2013
Base term, 20 years from filing
Today
Term ended Oct 26, 2026
2006
2026
Clock starts
Oct 26, 2006
Oct 26, 2006
Term ended
Oct 26, 2026
Oct 26, 2026
Granted
Dec 10, 2013
Dec 10, 2013
base term
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 26, 2006, when application 11/588,638, the earliest non-provisional in its chain, was filed (this one was filed Aug 24, 2010) | Oct 26, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Oct 26, 2026 | High confidence |
This family
| US 7,528,143 | In force no later than Nov 2031 | no later than Nov 2031 |
| US 7,825,246 | In force no later than Mar 2027 | no later than Mar 2027 |
| US 8,133,900 | In force Sep 2027 | Sep 2027 |
| US 8,138,199 | In force Jun 2028 | Jun 2028 |
| US 8,604,042 | this patent Oct 2026 | Oct 2026 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 18, 2010 Reel 25155, frame 16 | Noronha, Glenn; Mak, Chi Ching; Cao, Jianguo; Renick, Joel; McPherson, Andrew; Zeng, Binqi; Pathak, Ved P.; Lohse, Daniel L.; Hood, John D.; Soll, Richard M. | Targegen, Inc. | Assignment of Assignor's Interest |
| Oct 18, 2010 Reel 25155, frame 47 | Hood, John D.; Noronha, Glenn | Targegen, Inc. | Assignment of Assignor's Interest |
| Oct 29, 2013 Reel 31510, frame 268 | Noronha, Glenn; Mak, Chi Ching; Cao, Jianguo; Renick, Joel; McPherson, Andrew; Zeng, Binqi; Pathak, Ved P.; Lohse, Daniel L.; Hood, John D.; Soll, Richard M. | Targegen, Inc. | Corrective Assignment to Correct the State of Incorporation from a California Corporation to a Delaware Corporation for the Assignment Previously Recorded on Reel 025154 Frame 0975. Assignor(S) Hereby Confirms the State of Incorporation for Targegen, Inc. to Be a Delaware Corporation. |
| May 25, 2017 Reel 42586, frame 643 | Impact Therapeutics, Inc. | Impact Biomedicines, Inc. | Change of Name |
| May 25, 2017 Reel 42512, frame 179 | Targegen, Inc. | Impact Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 30, 2017 Reel 44572, frame 660 | Impact Biomedicines, Inc. | Lind S.A., LLC, as Collateral Agent | Security Interest |
| Feb 12, 2018 Reel 44904, frame 628 | Lind S.A. LLC, as Collateral Agent | Impact Biomedicines, Inc. | Release of Security Interest |
| Aug 21, 2019 Reel 50297, frame 562 | Targegen, Inc. | Impact Biomedicines, Inc. | Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 042512 Frame: 0179. Assignor(S) Hereby Confirms the Assignment . |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Citations
111
later US patents cite this one
That is top 5% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.